• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素通过诱导自噬和抑制 TFAP2A 介导的细胞外基质途径来抑制 LGR5(+)结直肠肿瘤干细胞。

Curcumin suppresses LGR5(+) colorectal cancer stem cells by inducing autophagy and via repressing TFAP2A-mediated ECM pathway.

机构信息

Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.

Department of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.

出版信息

J Nat Med. 2021 Jun;75(3):590-601. doi: 10.1007/s11418-021-01505-1. Epub 2021 Mar 13.

DOI:10.1007/s11418-021-01505-1
PMID:33713277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159825/
Abstract

Colorectal cancer stem cells (CSCs) have the potential for self-renewal, proliferation, and differentiation. And LGR5 is a stem cell marker gene of colorectal cancer. Curcumin can suppress oncogenicity of many cancer cells, yet the effect and mechanism of curcumin in LGR5(+) colorectal cancer stem cells (CSCs) have not been studied. In this study, we studied the effect of curcumin on LGR5(+) colorectal CSCs using the experiments of tumorsphere formation, cell viability and cell apoptosis. Then autophagy analysis, RNA-Seq, and real-time PCR were used to identify the mechanism responsible for the inhibition of LGR5(+) colorectal CSCs. Our results showed that curcumin inhibited tumorsphere formation, decreased cell viability in a dose-dependent manner, and also promoted apoptosis of LGR5(+) colorectal CSCs. Next, we found curcumin induced autophagy of LGR5(+) colorectal CSCs. When LGR5(+) colorectal CSCs were co-treated with curcumin and the autophagy inhibitor (hydroxychloroquine), curcumin-induced cell proliferation inhibition decreased. In addition, we also found that curcumin inhibited the extracellular matrix (ECM)-receptor interaction pathway via the downregulation of the following genes: GP1BB, COL9A3, COMP, AGRN, ITGB4, LAMA5, COL2A1, ITGB6, ITGA1, and TNC. Further, these genes were transcriptionally regulated by TFAP2A, and the high expression of TFAP2A was associated with poor prognosis in colorectal cancer. In conclusion, curcumin suppressed LGR5(+) colorectal CSCs, potentially by inducing autophagy and repressing the oncogenic TFAP2A-mediated ECM pathway.

摘要

结直肠肿瘤干细胞(CSCs)具有自我更新、增殖和分化的潜能。LGR5 是结直肠癌的干细胞标记基因。姜黄素可以抑制许多癌细胞的致癌性,但姜黄素对 LGR5(+)结直肠肿瘤干细胞(CSCs)的作用和机制尚未研究。本研究采用肿瘤球形成实验、细胞活力和细胞凋亡实验,研究了姜黄素对 LGR5(+)结直肠 CSCs 的作用。然后,利用自噬分析、RNA-Seq 和实时 PCR 来鉴定抑制 LGR5(+)结直肠 CSCs 的机制。研究结果表明,姜黄素抑制肿瘤球形成,呈剂量依赖性降低细胞活力,促进 LGR5(+)结直肠 CSCs 凋亡。接下来,发现姜黄素诱导 LGR5(+)结直肠 CSCs 自噬。当 LGR5(+)结直肠 CSCs 与姜黄素和自噬抑制剂(羟氯喹)共同处理时,姜黄素诱导的细胞增殖抑制作用降低。此外,还发现姜黄素通过下调以下基因抑制细胞外基质(ECM)-受体相互作用途径:GP1BB、COL9A3、COMP、AGRN、ITGB4、LAMA5、COL2A1、ITGB6、ITGA1 和 TNC。进一步研究发现,这些基因受 TFAP2A 的转录调控,TFAP2A 的高表达与结直肠癌的不良预后相关。总之,姜黄素抑制 LGR5(+)结直肠 CSCs,可能通过诱导自噬和抑制致癌 TFAP2A 介导的 ECM 途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/0d0dec2c57f3/11418_2021_1505_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/c0393a9ed436/11418_2021_1505_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/dea5caedfebf/11418_2021_1505_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/229b6e515d31/11418_2021_1505_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/407da0214fd6/11418_2021_1505_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/ebafa20af814/11418_2021_1505_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/bb2886650107/11418_2021_1505_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/0d0dec2c57f3/11418_2021_1505_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/c0393a9ed436/11418_2021_1505_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/dea5caedfebf/11418_2021_1505_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/229b6e515d31/11418_2021_1505_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/407da0214fd6/11418_2021_1505_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/ebafa20af814/11418_2021_1505_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/bb2886650107/11418_2021_1505_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503c/8159825/0d0dec2c57f3/11418_2021_1505_Fig7_HTML.jpg

相似文献

1
Curcumin suppresses LGR5(+) colorectal cancer stem cells by inducing autophagy and via repressing TFAP2A-mediated ECM pathway.姜黄素通过诱导自噬和抑制 TFAP2A 介导的细胞外基质途径来抑制 LGR5(+)结直肠肿瘤干细胞。
J Nat Med. 2021 Jun;75(3):590-601. doi: 10.1007/s11418-021-01505-1. Epub 2021 Mar 13.
2
LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.LGR5 促进宫颈癌中的癌症干细胞特性和化疗耐药性。
Cell Death Dis. 2017 Sep 7;8(9):e3039. doi: 10.1038/cddis.2017.393.
3
Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.针对 Lgr5 的单克隆抗体可识别人类结直肠肿瘤干细胞。
Stem Cells. 2012 Nov;30(11):2378-86. doi: 10.1002/stem.1233.
4
Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.Lgr5+CD44+EpCAM+严格定义了人类结直肠癌中的癌症干细胞。
Cell Physiol Biochem. 2018;46(2):860-872. doi: 10.1159/000488743. Epub 2018 Mar 29.
5
[TNF-α activates PI3K/AKT pathway to promote proliferation of SW620 colon cancer stem cells].肿瘤坏死因子-α激活磷脂酰肌醇-3激酶/蛋白激酶B信号通路促进SW620结肠癌干细胞增殖
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Jan;36(1):33-41.
6
Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.Lgr5 通过 ABCB1 在结直肠癌中促进癌症干细胞特性并赋予化疗耐药性。
Biomed Pharmacother. 2013 Oct;67(8):791-9. doi: 10.1016/j.biopha.2013.08.001. Epub 2013 Aug 23.
7
Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.Lgr5与CXCR4的共表达是结直肠癌癌干细胞样细胞的特征。
Oncotarget. 2016 Dec 6;7(49):81144-81155. doi: 10.18632/oncotarget.13214.
8
Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA.姜黄素促进了结肠癌干细胞亚群的自噬存活,而 DCLK1-siRNA 可以消除这些干细胞。
Cancer Res. 2014 May 1;74(9):2487-98. doi: 10.1158/0008-5472.CAN-13-3536. Epub 2014 Mar 13.
9
AQP5 complements LGR5 to determine the fates of gastric cancer stem cells through regulating ULK1 ubiquitination.水通道蛋白 5(AQP5)通过调节 ULK1 泛素化补充 LGR5 来决定胃癌干细胞的命运。
J Exp Clin Cancer Res. 2022 Nov 14;41(1):322. doi: 10.1186/s13046-022-02532-w.
10
Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.Lgr5(+) 结肠和直肠癌细胞干细胞的意义。
Ann Surg Oncol. 2011 Apr;18(4):1166-74. doi: 10.1245/s10434-010-1373-9. Epub 2010 Dec 2.

引用本文的文献

1
Hepatocellular carcinoma stem cells: the current state of small molecule-based inhibitors.肝细胞癌干细胞:基于小分子抑制剂的研究现状
Cell Death Dis. 2025 Sep 1;16(1):666. doi: 10.1038/s41419-025-07983-5.
2
KMT2D/ZNF460-induced COL9A1-mediated extracellular matrix stiffness maintains the cancer stem cell pool to promote colorectal cancer progression.KMT2D/ZNF460诱导的COL9A1介导的细胞外基质硬度维持癌症干细胞库以促进结直肠癌进展。
Cell Biol Toxicol. 2025 Jul 1;41(1):111. doi: 10.1007/s10565-025-10053-3.
3
The dual role of autophagy in cancer stem cells: implications for tumor progression and therapy resistance.

本文引用的文献

1
Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer.羟氯喹增强 BC001 在胃癌中的抗肿瘤作用。
Int J Oncol. 2019 Aug;55(2):405-414. doi: 10.3892/ijo.2019.4824. Epub 2019 Jun 12.
2
Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin.姜黄素通过调节整合素受体、胶原酶活性以及Nm23和E-钙黏蛋白的表达来展现抗转移特性。
J Environ Pathol Toxicol Oncol. 2003;22(1):49-58.
自噬在癌症干细胞中的双重作用:对肿瘤进展和治疗抗性的影响。
J Transl Med. 2025 May 25;23(1):583. doi: 10.1186/s12967-025-06595-z.
4
Betaine inhibits the stem cell-like properties of hepatocellular carcinoma by activating autophagy via SAM/mA/YTHDF1-mediated enhancement on ATG3 stability.甜菜碱通过SAM/mA/YTHDF1介导增强ATG3稳定性激活自噬,从而抑制肝细胞癌的干细胞样特性。
Theranostics. 2025 Jan 6;15(5):1949-1965. doi: 10.7150/thno.102682. eCollection 2025.
5
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance.LGR5:癌症转移和化疗耐药性的新兴治疗靶点。
Cancer Metastasis Rev. 2025 Jan 17;44(1):23. doi: 10.1007/s10555-024-10239-x.
6
-activated promotes lung adenocarcinoma progression and inhibits CD4/CD8 T-cell infiltrations by targeting signaling pathway.激活的[具体内容]通过靶向[具体信号通路]促进肺腺癌进展并抑制CD4/CD8 T细胞浸润。
Transl Lung Cancer Res. 2024 Sep 30;13(9):2116-2138. doi: 10.21037/tlcr-24-50. Epub 2024 Sep 10.
7
ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.ADAMTSL2 是结直肠癌潜在的预后生物标志物和免疫治疗靶点:生物信息学分析和实验验证。
PLoS One. 2024 May 30;19(5):e0303909. doi: 10.1371/journal.pone.0303909. eCollection 2024.
8
Drug repurposing for cancer therapy.药物重用于癌症治疗。
Signal Transduct Target Ther. 2024 Apr 19;9(1):92. doi: 10.1038/s41392-024-01808-1.
9
LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy.LGR5 作为抗体功能化仿生磁脂体治疗结肠癌的治疗靶点。
Int J Nanomedicine. 2024 Feb 23;19:1843-1865. doi: 10.2147/IJN.S440881. eCollection 2024.
10
Mechanism of miR-7 mediating TLR4/TRAF6/NF-κB inflammatory pathway in colorectal cancer.miR-7介导结直肠癌中TLR4/TRAF6/NF-κB炎症通路的机制
Funct Integr Genomics. 2024 Feb 5;24(1):24. doi: 10.1007/s10142-024-01307-0.